Neoscreen Medical Ltd

Neoscreen was founded in 2007 and it is involved in the development and application of genetics test regarding prenatal testing, carrier screening (testing for future parents), hereditary cancer syndromes, congenital heart diseases, pharmacogenomics profiling (effect of genotype on drug response) as well as expanded neonatal screening. In addition, Neoscreen offers whole genome sequencing as a diagnostic tool for serious diseases. Since its establishment it collaborates with private hospitals (IASO, IASO Thesallia, REA, GAIA, EUROPEAN INTERBALKAN MEDICAL CENTER), In Vitro Fertilization (IVF) centers, doctors, stem cell companies (Omnigen), the Breast Center in Ippokrateio Hospital under the direction of Professor Mr. G.Zografos, with EKKAN, the Congenital Heart Diseases Center in Ippokrateio Hospital under the direction of Dr. A. Anastasakis and professor Mr. X. Stefanades, providing services of high quality. A total of more than 80.000 newborns have been subjected to Neonatal Testi...